Loss of Y Chromosome May Signal Early Cancer Risk Worldwide

Imagine a tiny chromosome slipping away, cell by cell, and leaving a trail that nudges tissue toward disease. That image, unsettling as it sounds, is emerging from a major new analysis of human tissues.

Researchers at the University of Arizona examined more than 1,000 tissue samples from roughly 400 male donors across 11 organs to map where the Y chromosome persists — and where it does not. By comparing normal tissue, precancerous areas and malignant epithelial tumors (carcinomas), the team uncovered a clear pattern: the mosaic loss of the Y chromosome tends to accumulate near tumors.

On paper the Y chromosome looks almost negligible. It's small compared with other chromosomes, and cells can often survive with two Xs and no Y. In practice, though, its absence creates a genetic ripple effect. This mosaic loss — where islands of cells lack the Y while others keep it — becomes more common with age. About 40 percent of men in their seventies show regions missing the Y, and by age 90 that fraction climbs toward 60 percent. Past work has already linked that mosaicism to chronic kidney failure, tissue fibrosis and a higher risk of severe COVID-19.

The Arizona study took the next step: mapping Y loss in tissue neighborhoods around tumors. The result reshapes how scientists think about tumor emergence. The closer a sample sits to a carcinoma, the more pronounced the loss of the Y chromosome. 'We now see it like a slope that steepens,' said Dr. Dan Teodorescu, the study's lead author. 'Tissues nearer the tumor show progressively greater depletion of Y.' This graded decline corresponds with downregulation of Y-linked genes and a broader weakening of the tissue's defenses.

The study suggests that local, mosaic loss of the Y chromosome creates a field effect that leaves epithelial tissue prone to carcinomas.

Why might that happen? The researchers argue that sustained loss of Y in a region promotes low-level inflammation and impairs normal cell functions, tilting the microenvironment toward instability. Similar patterns have been observed in patients with heart failure where lower Y levels associate with worse vascular dysfunction, reinforcing the idea that this chromosome helps preserve tissue integrity beyond sex determination.

Published in JCI Insight, the work does not claim causation yet. But it offers a provocative possibility: mosaic loss of the Y chromosome could serve as an early warning — a molecular harbinger that a patch of tissue is becoming vulnerable to malignant transformation. Could monitoring Y loss become part of future cancer risk assessment? The findings demand follow-up, and they open a new window onto how a seemingly small omission in our genome can have outsized consequences.